CircRNA Synthesis Market Size, Share, and Trends 2024 to 2034

The global circRNA synthesis market size is calculated at USD 214.22 million in 2025 and is forecasted to reach around USD 808.36 million by 2034, accelerating at a CAGR of 15.90% from 2025 to 2034. The North America market size surpassed USD 85.02 million in 2024 and is expanding at a CAGR of 16.03% during the forecast period. The market sizing and forecasts are revenue-based (USD Million/Billion), with 2024 as the base year.

  • Last Updated : March 2025
  • Report Code : 5652
  • Category : Healthcare

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID-19 Impact on CircRNA Synthesis Market 

5.1. COVID-19 Landscape: CircRNA Synthesis Industry Impact

5.2. COVID-19 - Impact Assessment for the Industry

5.3. COVID-19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global CircRNA Synthesis Market, By Product & Service

8.1. CircRNA Synthesis Market, by Product & Service

8.1.1 Instruments

8.1.1.1. Market Revenue and Forecast

8.1.2. Reagents & Kits

8.1.2.1. Market Revenue and Forecast

8.1.3. Services

8.1.3.1. Market Revenue and Forecast

Chapter 9. Global CircRNA Synthesis Market, By Application

9.1. CircRNA Synthesis Market, by Application

9.1.1. Drug Discovery

9.1.1.1. Market Revenue and Forecast

9.1.2. Therapeutics Development

9.1.2.1. Market Revenue and Forecast

9.1.3. Other

9.1.3.1. Market Revenue and Forecast

Chapter 10. Global CircRNA Synthesis Market, By End Use

10.1. CircRNA Synthesis Market, by End Use

10.1.1. Academic & Research Institutes

10.1.1.1. Market Revenue and Forecast

10.1.2. Pharmaceutical & Biotechnology Companies

10.1.2.1. Market Revenue and Forecast

10.1.3. Others

10.1.3.1. Market Revenue and Forecast

Chapter 11. Global CircRNA Synthesis Market, Regional Estimates and Trend Forecast

11.1. North America

11.1.1. Market Revenue and Forecast, by Product & Service

11.1.2. Market Revenue and Forecast, by Application

11.1.3. Market Revenue and Forecast, by End Use

11.1.4. U.S.

11.1.4.1. Market Revenue and Forecast, by Product & Service

11.1.4.2. Market Revenue and Forecast, by Application

11.1.4.3. Market Revenue and Forecast, by End Use

11.1.5. Rest of North America

11.1.5.1. Market Revenue and Forecast, by Product & Service

11.1.5.2. Market Revenue and Forecast, by Application

11.1.5.3. Market Revenue and Forecast, by End Use

11.2. Europe

11.2.1. Market Revenue and Forecast, by Product & Service

11.2.2. Market Revenue and Forecast, by Application

11.2.3. Market Revenue and Forecast, by End Use

11.2.4. UK

11.2.4.1. Market Revenue and Forecast, by Product & Service

11.2.4.2. Market Revenue and Forecast, by Application

11.2.4.3. Market Revenue and Forecast, by End Use

11.2.5. Germany

11.2.5.1. Market Revenue and Forecast, by Product & Service

11.2.5.2. Market Revenue and Forecast, by Application

11.2.5.3. Market Revenue and Forecast, by End Use

11.2.6. France

11.2.6.1. Market Revenue and Forecast, by Product & Service

11.2.6.2. Market Revenue and Forecast, by Application

11.2.6.3. Market Revenue and Forecast, by End Use

11.2.7. Rest of Europe

11.2.7.1. Market Revenue and Forecast, by Product & Service

11.2.7.2. Market Revenue and Forecast, by Application

11.2.7.3. Market Revenue and Forecast, by End Use

11.3. APAC

11.3.1. Market Revenue and Forecast, by Product & Service

11.3.2. Market Revenue and Forecast, by Application

11.3.3. Market Revenue and Forecast, by End Use

11.3.4. India

11.3.4.1. Market Revenue and Forecast, by Product & Service

11.3.4.2. Market Revenue and Forecast, by Application

11.3.4.3. Market Revenue and Forecast, by End Use

11.3.5. China

11.3.5.1. Market Revenue and Forecast, by Product & Service

11.3.5.2. Market Revenue and Forecast, by Application

11.3.5.3. Market Revenue and Forecast, by End Use

11.3.6. Japan

11.3.6.1. Market Revenue and Forecast, by Product & Service

11.3.6.2. Market Revenue and Forecast, by Application

11.3.6.3. Market Revenue and Forecast, by End Use

11.3.7. Rest of APAC

11.3.7.1. Market Revenue and Forecast, by Product & Service

11.3.7.2. Market Revenue and Forecast, by Application

11.3.7.3. Market Revenue and Forecast, by End Use

11.4. MEA

11.4.1. Market Revenue and Forecast, by Product & Service

11.4.2. Market Revenue and Forecast, by Application

11.4.3. Market Revenue and Forecast, by End Use

11.4.4. GCC

11.4.4.1. Market Revenue and Forecast, by Product & Service

11.4.4.2. Market Revenue and Forecast, by Application

11.4.4.3. Market Revenue and Forecast, by End Use

11.4.5. North Africa

11.4.5.1. Market Revenue and Forecast, by Product & Service

11.4.5.2. Market Revenue and Forecast, by Application

11.4.5.3. Market Revenue and Forecast, by End Use

11.4.6. South Africa

11.4.6.1. Market Revenue and Forecast, by Product & Service

11.4.6.2. Market Revenue and Forecast, by Application

11.4.6.3. Market Revenue and Forecast, by End Use

11.4.7. Rest of MEA

11.4.7.1. Market Revenue and Forecast, by Product & Service

11.4.7.2. Market Revenue and Forecast, by Application

11.4.7.3. Market Revenue and Forecast, by End Use

11.5. Latin America

11.5.1. Market Revenue and Forecast, by Product & Service

11.5.2. Market Revenue and Forecast, by Application

11.5.3. Market Revenue and Forecast, by End Use

11.5.4. Brazil

11.5.4.1. Market Revenue and Forecast, by Product & Service

11.5.4.2. Market Revenue and Forecast, by Application

11.5.4.3. Market Revenue and Forecast, by End Use

11.5.5. Rest of LATAM

11.5.5.1. Market Revenue and Forecast, by Product & Service

11.5.5.2. Market Revenue and Forecast, by Application

11.5.5.3. Market Revenue and Forecast, by End Use

Chapter 12. Company Profiles

12.1. Amerigo Scientific

12.1.1. Company Overview

12.1.2. Product Offerings

12.1.3. Financial Performance

12.1.4. Recent Initiatives

12.2. Applied Biological Materials Inc.

12.2.1. Company Overview

12.2.2. Product Offerings

12.2.3. Financial Performance

12.2.4. Recent Initiatives

12.3. BOC Sciences

12.3.1. Company Overview

12.3.2. Product Offerings

12.3.3. Financial Performance

12.3.4. Recent Initiatives

12.4. Creative Biogene.

12.4.1. Company Overview

12.4.2. Product Offerings

12.4.3. Financial Performance

12.4.4. Recent Initiatives

12.5. Creative Biolabs

12.5.1. Company Overview

12.5.2. Product Offerings

12.5.3. Financial Performance

12.5.4. Recent Initiatives

12.6. GeneCopoeia, Inc.

12.6.1. Company Overview

12.6.2. Product Offerings

12.6.3. Financial Performance

12.6.4. Recent Initiatives

12.7. GenScript

12.7.1. Company Overview

12.7.2. Product Offerings

12.7.3. Financial Performance

12.7.4. Recent Initiatives

12.8. Guangzhou Geneseed Biotech. Co., Ltd.

12.8.1. Company Overview

12.8.2. Product Offerings

12.8.3. Financial Performance

12.8.4. Recent Initiatives

12.9. LGC Biosearch Technologies

12.9.1. Company Overview

12.9.2. Product Offerings

12.9.3. Financial Performance

12.9.4. Recent Initiatives

12.10. SBS Genetech

12.10.1. Company Overview

12.10.2. Product Offerings

12.10.3. Financial Performance

12.10.4. Recent Initiatives

Chapter 13. Research Methodology

13.1. Primary Research

13.2. Secondary Research

13.3. Assumptions

Chapter 14. Appendix

14.1. About Us

14.2. Glossary of Terms

For questions or customization requests, please reach out to us at sales@precedenceresearch.com

Frequently Asked Questions

The global circRNA synthesis market size is expected to grow from USD 184.83 million in 2024 to USD 808.36 million by 2034.

The circRNA synthesis market is anticipated to grow at a CAGR of 15.90% between 2025 and 2034.

The major players operating in the circRNA synthesis market are Amerigo Scientific, Applied Biological Materials Inc., BOC Sciences, Creative Biogene., Creative Biolabs, GeneCopoeia, Inc., GenScript Guangzhou Geneseed Biotech. Co., Ltd., LGC Biosearch Technologies, SBS Genetech, and Others.

The driving factors of the circRNA synthesis market are the growing demand for next-generation RNA molecules is anticipated to boost the circRNA synthesis market in the coming years.

North America region will lead the global circRNA synthesis market during the forecast period 2025 to 2034.

Ask For Sample

No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client